trending Market Intelligence /marketintelligence/en/news-insights/trending/ub5tq5yxr7pr7qgimwzilq2 content esgSubNav
In This List

Rakuten invests in Japanese genetic testing company Genesis

Blog

Using ESG Analysis to Support a Sustainable Future

Video

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Q&A: Streamlining Analytics for TCFD Reporting

Blog

Evergrande and the wider impact: a sentiment analytics based perspective


Rakuten invests in Japanese genetic testing company Genesis

Japanese genetic testing company Genesis Healthcare Co. said Feb. 27 that online retailer Rakuten Inc. and Omron Healthcare Co. Ltd. invested in Genesis to bring its valuation to ¥42 billion.

The details of the investment were not disclosed. Genesis said that this was Rakuten's second investment in Genesis. The retailer bought about ¥1.4 billion worth of Genesis shares in August 2017.

As of Feb. 26, US$1 was equivalent to ¥106.92.